Skip to content
DataLookout
Menu

Viatris Inc. clinical trial pipeline

Get alerts when Viatris Inc.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-21

What changed in the last 30 days

2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.

  1. Notable: MR-146 · MR-146 · Stage I and Stage II Neurotrophic Keratopathy Primary endpoint(s) modified Viatris Inc.Phase 1/2 NCT07923045
  2. Minor: Dymista in Chinese Adolescents Trial completed Viatris Inc.Phase 4 NCT07597473
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-11-06 NCT07923045 A Phase 1/2 Clinical Trial to Evaluate the Safety and Efficacy of MR-146 in Subjects With… Phase 1/2 Recruiting

Active trials by phase

Phase 1/2
1
Phase 4
1
Get alerts when Viatris Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free